Ephor
  • Home
  • Calendar
  • News archive
  • Links
  • Contact
  • FAQ
  • Sign up
  • Nederlands
  • English

Adjudication ADR OPERAM study

Home » News archive » Geen categorie » Adjudication ADR OPERAM study
Method to calculate time to benefitA survey of geriatric expertise in medicines evaluation at national regulatory agencies in Europe: There is still room for improvement!

The OPERAM study, towards optimization of polypharmacy with support of the STRIP method and the STRIPassistant, has finished the protocol and will start at the end of this year with the inclusion of the first patients. At the EUGMS a poster is presented of the adjudication of the ADR. The postar is available at this website at Abstracts and Posters

10/10/2016 Geen categorieeverywhereIMLeave a comment

Leave a Reply (Cancel reply)

You must be logged in to post a comment.

Recent Posts

  • Adverse drug reactions in older people
  • Two Ephor medals granted
  • OPERAM study has included 2000 patients
  • Prof. Mirko Petrovic appointed as EuGMS Academic Director
  • 180 seconds for the future of therapy for multi-morbid older people
  • SENATOR Patient Recruitment finished
  • Reflection paper on physical frailty approved by EMA
  • Action plan of EMA to improve the product information for EU medicines
  • The Reflection paper for the older population should be a guideline
  • EMA relocate to Amsterdam

Contacts

Street, City, Country
1-800-200-8765
info@caremedical.com
care-skype-name
Care logo

Medical

  • Clinics & Centers
  • Conditions & Treatments
  • Find a Doctor
  • Get My Medical Records
  • Medicare Plan Finder
  • Orthopedic Care

Common Links

  • Careers
  • Donate
  • Get Directions & Hours
  • Hospital News
  • Packages & Promotions
  • Research & Innovations

Care WordPress Theme

Care is a premium WordPress theme for doctors, dentists and health clinics, and is great for health related blogs. Available exclusively on Theme Forest.

All images used for preview are copyrighted by their respective owners.

© 2020 Ephor

Disclaimer

Farmacotherapeutisch Kompas

  • Home
  • Calendar
  • News archive
  • Links
  • Contact
  • FAQ
  • Sign up
  • Nederlands
  • English